Esperance Pharmaceuticals Revenue and Competitors

Location

$28.7M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Esperance Pharmaceuticals's estimated annual revenue is currently $1.1M per year.(i)
  • Esperance Pharmaceuticals's estimated revenue per employee is $100,500
  • Esperance Pharmaceuticals's total funding is $28.7M.

Employee Data

  • Esperance Pharmaceuticals has 11 Employees.(i)
  • Esperance Pharmaceuticals grew their employee count by -8% last year.

Esperance Pharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.1M11-8%$28.7MN/A
#2
$5.8M290%N/AN/A
#3
$7.6M386%N/AN/A
#4
$13.9M6917%N/AN/A
#5
$29.9M14930%N/AN/A
#6
$101.5M505-9%N/AN/A
#7
$10.5M520%N/AN/A
#8
$1.6M833%N/AN/A
#9
$43.8M21821%N/AN/A
#10
$12.3M6117%N/AN/A
Add Company

What Is Esperance Pharmaceuticals?

Esperance Pharmaceuticals, Inc. is developing a new class of targeted anticancer drugs that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cell's surface. The drugs kill even those cells known to be resistant to chemotherapeutic drugs.

keywords:N/A

$28.7M

Total Funding

11

Number of Employees

$1.1M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Esperance Pharmaceuticals News

2022-03-22 - Critical cystic fibrosis drug now on PBS

... the price after it was placed on the pharmaceutical benefits scheme. ... country manager of Vertex Pharmaceuticals Sabrina Barbic said.

2022-03-22 - Peptide Therapeutics: Contract API Manufacturing Market ...

As pharma companies resume full-scale operation after the COVID-19 outbreak, ... Enzo Life Sciences; EOC Pharma; Esperance Pharmaceuticals...

2011-06-01 - Esperance Pharmaceuticals Holds First Close of $7.5M Series B Financing

Esperance Pharmaceuticals, Inc., a Baton Rouge, LA-based clinical stage company developing a new class of targeted anticancer drugs, has held the first close of a $7.5m Series B financing. The round was led by Sanofi, which committed $4.5m, with participation from existing investors Louisiana F ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M11N/AN/A
#2
$1M11N/AN/A
#3
$1M1138%N/A
#4
$1.4M110%N/A
#5
$1.3M11-21%N/A